A Case Report of Ketamine-induced Hypoglycemia in Treatment Resistance Depression
Issued Date
2024-08-01
Resource Type
ISSN
17381088
eISSN
20934327
Scopus ID
2-s2.0-85200628488
Journal Title
Clinical Psychopharmacology and Neuroscience
Volume
22
Issue
3
Start Page
541
End Page
543
Rights Holder(s)
SCOPUS
Bibliographic Citation
Clinical Psychopharmacology and Neuroscience Vol.22 No.3 (2024) , 541-543
Suggested Citation
Lortrakul J., Pattanaseri K. A Case Report of Ketamine-induced Hypoglycemia in Treatment Resistance Depression. Clinical Psychopharmacology and Neuroscience Vol.22 No.3 (2024) , 541-543. 543. doi:10.9758/cpn.23.1155 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/100472
Title
A Case Report of Ketamine-induced Hypoglycemia in Treatment Resistance Depression
Author(s)
Author's Affiliation
Corresponding Author(s)
Other Contributor(s)
Abstract
Ketamine therapy can reduce the risk of suicide and depression in the treatment resistant patient. Adverse effects of ketamine infusion include blurred vision, nausea and vomiting, hepatotoxicity, headache, and cystitis. However, the effect of ketamine infusion on blood glucose remains unclear. This report describes several episodes of hypoglycemia in a 36-year-old man with type 1 diabetes mellitus after ketamine infusion for treatment-resistance depression. He has been receiving subcutaneous insulin injection and denied any severe hypoglycemia events in the prior 20 years. He had unsuccessful treatment for depression. His depressive conditions were subsequently improved due to ketamine therapy, however, he had recurrent hypoglycemia episodes. Clinicians should be aware of this potential adverse effect on initiating ketamine infusion with patients who had type 1 diabetes.